Avecho Biotechnology Ltd Cash Flow Reinvestment Rate
Avecho Biotechnology Ltd cash flow reinvestment rate. Avecho Biotechnology Ltd (AVE) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$2.27 Million. Explore cash flow to debt ratio of Avecho Biotechnology Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Avecho Biotechnology Ltd (1993–2025)
Cash flow reinvestment rate of Avecho Biotechnology Ltd from 1993 to 2025. Historical reinvestment intensity for Avecho Biotechnology Ltd across 3 annual periods. Explore AVE capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Avecho Biotechnology Ltd Cash Flow Reinvestment Rate by Year (1993–2025)
Avecho Biotechnology Ltd cash flow reinvestment rate by year from 1993 to 2025. Year-by-year capital reinvestment analysis for Avecho Biotechnology Ltd. For the full cash flow conversion analysis, see AVE cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | AU$0.00 | AU$1.10 Million | AU$0.00 | ▼ -100.0% |
| 2019 | 0.01x | AU$16.21K | AU$1.19 Million | AU$5.15K | — |
| 1993 | 0.00x | AU$0.00 | AU$23.00K | AU$0.00 | — |